Viewing Study NCT06015750


Ignite Creation Date: 2025-12-24 @ 5:12 PM
Ignite Modification Date: 2026-01-05 @ 3:57 AM
Study NCT ID: NCT06015750
Status: WITHDRAWN
Last Update Posted: 2025-12-18
First Post: 2023-08-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module